Craig Beasley is currently Chief Technology Officer at BlueRock Therapeutics.  Since joining BlueRock in August of 2021, he is responsible for Technical Operations which includes cell line derivation, process development, manufacturing, facilities and engineering, lab operations, and analytical sciences.

Prior to joining BlueRock, Craig served as Vice President, Cell Therapy Supply Chain and Patient Operations at Juno/BMS starting in 2016.  He was responsible for BMS’s cell therapy assets (clinical and commercial stage).  This includes demand and supply planning, patient operations, external manufacturing  

Prior to joining Juno Therapeutics, Craig was Vice President of Next Generation Manufacturing at Biogen.  During his 17 years with Biogen, Craig held leadership positions throughout the technical operations group (Engineering, Manufacturing, Quality, and Supply Chain).